@article{7f413125b13548a4937f9c3f0cd962c9,
title = "How Ophthalmologists Can Decarbonize Eye Care: A Review of Existing Sustainability Strategies and Steps Ophthalmologists Can Take",
abstract = "Topic: Understanding approaches to sustainability in cataract surgery and their risks and benefits. Clinical Relevance: In the United States, health care is responsible for approximately 8.5% of greenhouse gas (GHG), and cataract surgery is one of the most commonly performed surgical procedures. Ophthalmologists can contribute to reducing GHG emissions, which lead to a steadily increasing list of health concerns ranging from trauma to food instability. Methods: We conducted a literature review to identify the benefits and risks of sustainability interventions. We then organized these interventions into a decision tree for use by individual surgeons. Results: Identified sustainability interventions fall into the domains of advocacy and education, pharmaceuticals, process, and supplies and waste. Existing literature shows certain interventions may be safe, cost-effective, and environmentally friendly. These include dispensing medications at home to patients after surgery, multi-dosing appropriate medications, training staff to properly sort medical waste, reducing the number of supplies used during surgery, and implementing immediate sequential bilateral cataract surgery where clinically appropriate. The literature was lacking on the benefits or risks for some interventions, such as switching specific single-use supplies to reusables or implementing a hub-and-spoke–style operating room setup. Many of the advocacy and education interventions have inadequate literature specific to ophthalmology but are likely to have minimal risks. Conclusions: Ophthalmologists can engage in a variety of safe and effective approaches to reduce or eliminate dangerous GHG emissions associated with cataract surgery. Financial Disclosure(s): Proprietary or commercial disclosure may be found after the references.",
keywords = "Carbon emissions, Cataracts, Climate change, Efficiency, Greenhouse gases, Health care delivery, Life cycle assessment, Quality, Surgery, Sustainability, Value",
author = "Brooke Sherry and Samuel Lee and {Ramos Cadena}, {Maria De Los Angeles} and Gregory Laynor and Patel, {Sheel R.} and Simon, {Maxine della Badia} and Romanowski, {Eric G.} and Hochman, {Sarah E.} and Schuman, {Joel S.} and Christina Prescott and Thiel, {Cassandra L.}",
note = "Funding Information: C.T.: Support to primary investigator{\textquoteright}s (PI) institution – The Patrick and Catherine Weldon Donaghue Medical Research Foundation's Greater Value Portfolio, National Eye Institute of the National Institutes of Health (award number R56EY033779); Grants – NSF RAPID: Variation in Resilience Under Shortages in the Medical Supply Chain (to PI institution); Consulting fees – Clinically Sustainable Consulting LLC (PI owns this LLC), Philips (to PI), Stryker Corporation , Becton Dickinson, CUE Health, Zasti, Inc, Association for Medical Device Reprocessors, Institute for Healthcare Improvement , NYU Stern School of Business, University of California San Francisco, The Sean N. Parker Center for Allergy and Asthma Research at Stanford University, EarthShift Global (through the LLC); Payment or honoraria – Columbia University{\textquoteright}s SHARP program (through the LLC); Leadership or fiduciary role – Mass General Center for Climate and Health advisory board (unpaid); Stock or stock options – Zabble, Inc. (to PI). Funding Information: Funding received in support of this publication: The Patrick and Catherine Weldon Donaghue Medical Research Foundation's Greater Value Portfolio and the National Eye Institute of the National Institutes of Health under Award Number R56EY033779. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. Funding Information: C.T.: Support to primary investigator's (PI) institution – The Patrick and Catherine Weldon Donaghue Medical Research Foundation's Greater Value Portfolio, National Eye Institute of the National Institutes of Health (award number R56EY033779); Grants – NSF RAPID: Variation in Resilience Under Shortages in the Medical Supply Chain (to PI institution); Consulting fees – Clinically Sustainable Consulting LLC (PI owns this LLC), Philips (to PI), Stryker Corporation, Becton Dickinson, CUE Health, Zasti, Inc, Association for Medical Device Reprocessors, Institute for Healthcare Improvement, NYU Stern School of Business, University of California San Francisco, The Sean N. Parker Center for Allergy and Asthma Research at Stanford University, EarthShift Global (through the LLC); Payment or honoraria – Columbia University's SHARP program (through the LLC); Leadership or fiduciary role – Mass General Center for Climate and Health advisory board (unpaid); Stock or stock options – Zabble, Inc. (to PI).C.R.P.: Consulting fees – Johnson & Johnson Vision; Payment for expert testimony – Children's Hospital of Philadelphia, Washington University; Data Safety Monitoring/Advisory Board – DSMC SCUT2 trial, DSMC ZEDS trial; Leadership or fiduciary role in other board – Vice President of Eye and Contact Lens Association (unpaid).Funding received in support of this publication: The Patrick and Catherine Weldon Donaghue Medical Research Foundation's Greater Value Portfolio and the National Eye Institute of the National Institutes of Health under Award Number R56EY033779. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. Obtained funding: N/A Publisher Copyright: {\textcopyright} 2023 American Academy of Ophthalmology",
year = "2023",
month = jul,
doi = "10.1016/j.ophtha.2023.02.028",
language = "English (US)",
volume = "130",
pages = "702--714",
journal = "Ophthalmology",
issn = "0161-6420",
publisher = "Elsevier Inc.",
number = "7",
}